METS_IQ  >  EVIDENCE  >  CASE STUDIES

GLP-1 Plateau Management 

How objective metabolic measurement informed intervention and supported continued clinical progress. 
This is some text inside of a div block.
5 min read

AGE

38 Years

CLINICAL FOCUS

GLP-1 Therapy

DURATION

11 Months

PRIMARY GOAL

Weight Loss &
Metabolic Health

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5
Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

  1. Item 1
  2. Item 2
  3. Item 3

Unordered list

  • Item A
  • Item B
  • Item C

Text link

Bold text

Emphasis

Superscript

Subscript

Key Metabolic Findings

FAT OXIDATION

0% → 76%

WEIGHT CHANGE

-22.4 kg

MUSCLE LOSS

<0.5 kg

BODY MEASUREMENTS

-44 cm

Heading 1

Heading 2

Heading 3

Heading 4

Heading 5
Heading 6

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore eu fugiat nulla pariatur.

Block quote

Ordered list

  1. Item 1
  2. Item 2
  3. Item 3

Unordered list

  • Item A
  • Item B
  • Item C

Text link

Bold text

Emphasis

Superscript

Subscript

Clinical Insight

Weight loss alone did not explain patient progress. Objective metabolic measurement demonstrated restoration of fat oxidation, preservation of lean tissue and improved metabolic flexibility, enabling intervention to be adjusted throughout care. This case illustrates how METS_iQ supports more structured and measurable obesity management.